Alfa Thermodiagnostics has engineered a next-generation whole-body thermometry system intended for measuring differences in the skin surface temperatures only. AlfaSight™ is grounded in the established science of regulation thermography which was invented and first commercialized in Germany more than 25 years ago. It is a proven, accurate technology supported by more than 100,000 patient assessments.
Founder Dr. Daniel Beilin led the United States FDA clearance of the first-generation regulation thermography technology in 1996 and also ushered Alfa's next-generation regulation thermometry™ system through FDA clearance. He is recognized worldwide as the foremost authority on whole-body thermometry and is supported by leaders in the fields of radiology, neurobiology and regulation medicine.
AlfaSight™ is a non-invasive patient assessment tool that identifies skin temperature changes before and after a cool-air stress is applied.